Status:
COMPLETED
Long Term Antihypertensive Exposure and Adverse Metabolic Effects: PEAR Follow-Up Study
Lead Sponsor:
University of Florida
Conditions:
Drug Induced Hyperglycemia
Secondary Hyperlipidemia
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
This is a research study of the long term effects on blood sugar and cholesterol of blood pressure lowering medications. People are invited to participate in this research study if they participated i...
Detailed Description
One in three deaths in the United States is due to cardiovascular (CV) disease. One in three US adults has hypertension, a major underlying cause of CV disease. Type 2 diabetes (T2D) and dyslipidemia ...
Eligibility Criteria
Inclusion
- previously enrolled in PEAR study
- completed last PEAR study visit greater than 6 months prior
- receive thiazide diuretic continuously since PEAR enrollment
Exclusion
- pregnancy
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT01409434
Start Date
June 1 2010
End Date
August 1 2013
Last Update
October 16 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida College of Pharmacy
Gainesville, Florida, United States, 32610